Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCNKS.L Regulatory News (CNKS)

  • There is currently no data for CNKS

Board Changes

6 May 2021 15:06

RNS Number : 8269X
Cenkos Securities PLC
06 May 2021
 

6 May 2021

Cenkos Securities plc

("Cenkos" or the "Company")

 

Board Changes

 

Further to the announcement released on 9 December 2020 relating to the retirement of Jim Durkin, Chief Executive Officer, at the forthcoming Annual General Meeting, and the appointment of Julian Morse as the new Chief Executive Officer, the Board is pleased to confirm that Julian's appointment has now received regulatory approval from the Financial Conduct Authority. Julian will be appointed to the position of Chief Executive Officer which will take place immediately following the Company's Annual General Meeting on 12 May 2021.

 

The Board is also pleased to announce that Jeremy Osler's appointment as an Executive Director of the Company, has also received regulatory approval from the Financial Conduct Authority. Jeremy will join the Board immediately following the Company's Annual General Meeting on 12 May 2021.

 

Commenting on the Board changes, Lisa Gordon Non-Executive Chairman said:

 

"On behalf of the Board I would like to pay tribute to Jim Durkin, who has been central to the creation and development of Cenkos over the past 16 years. I have hugely enjoyed working with Jim over the last 12 months on the blueprint for Cenkos' ongoing success and we wish him well in his forthcoming retirement.

 

The appointment of Julian Morse as Chief Executive Officer and wider changes to the senior management team across the Firm, including the appointment of Jeremy Osler to the Board as Executive Director, creates a strong team to lead and take the business forward." 

 

For further information, please contact:

Cenkos Securities plc

Lisa Gordon, Non-Executive Chairman

Julian Morse, Executive Director Tel: 0207 397 8900

 

SPARK Advisory Partners Limited

Matt Davis, Nominated Adviser Tel: 0203 368 3552

 

The Nisse Consultancy - Public relations

Jason Nisse Tel: 07769 688618

Andrew Garfield Tel: 07974 982337

 

 

Additional Information 

The only change to the information previously supplied on 9 December 2020 in respect of Jeremy Osler's appointment as required under Schedule 2(g) of the AIM Rules is that his current interest in the Company's share capital is now made up of:  

 

49,627 Ordinary shares held in an ordinary managed account.

93,470 Ordinary shares held in accordance with the terms and conditions of Company's Deferred Bonus Scheme.

8,274 Ordinary shares held in the Company's Share Incentive Plan.

Option over 44,698 Ordinary shares held under the Company's Save As You Earn Plan. These options are at 40.27pence. These options expire on 30 June 2024.

Option over 40,000 Ordinary shares held under the Company's Share Option Plan. These options are at 73.50 pence, subject to a performance condition, and vest in April 2024.

A nil cost Option over 510,000 Ordinary shares held under the Company's Long Term Incentive Plan. These options are subject to a performance condition and vest equally in April 2024, 2025 and 2026.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAAFMITMTMMBJB
Date   Source Headline
10th Mar 202110:23 amRNSForm 8.5 (EPT/NON-RI)
9th Mar 20218:27 amRNSForm 8.5 (EPT/NON-RI)
8th Mar 20218:44 amRNSForm 8.5 (EPT/NON-RI)
5th Mar 20218:59 amRNSForm 8.5 (EPT/NON-RI)
4th Mar 20218:43 amRNSForm 8.5 (EPT/NON-RI)
2nd Mar 20219:22 amRNSForm 8.5 (EPT/NON-RI)
26th Feb 20219:44 amRNSForm 8.5 (EPT/NON-RI)
25th Feb 20218:23 amRNSForm 8.5 (EPT/NON-RI)
24th Feb 20218:16 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 202110:57 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 202110:51 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 202110:45 amRNSForm 8.5 (EPT/NON-RI)
22nd Feb 20218:28 amRNSForm 8.5 (EPT/NON-RI)
19th Feb 20218:32 amRNSForm 8.5 (EPT/NON-RI)
18th Feb 20218:29 amRNSForm 8.5 (EPT/NON-RI)
17th Feb 20219:11 amRNSForm 8.5 (EPT/NON-RI)
12th Feb 20219:21 amRNSForm 8.5 (EPT/NON-RI)
11th Feb 20219:26 amRNSForm 8.5 (EPT/NON-RI)
10th Feb 20219:54 amRNSForm 8.5 (EPT/NON-RI)
9th Feb 20218:16 amRNSForm 8.5 (EPT/NON-RI)
8th Feb 20218:26 amRNSForm 8.5 (EPT/NON-RI)
5th Feb 20218:39 amRNSForm 8.5 (EPT/NON-RI)
3rd Feb 20218:07 amRNSForm 8.5 (EPT/NON-RI)
1st Feb 20219:20 amRNSForm 8.5 (EPT/NON-RI)
29th Jan 20219:22 amRNSForm 8.5 (EPT/NON-RI)
28th Jan 20218:36 amRNSForm 8.5 (EPT/NON-RI)
27th Jan 20218:53 amRNSForm 8.5 (EPT/NON-RI)
26th Jan 20219:47 amRNSForm 8.5 (EPT/NON-RI)
25th Jan 20218:18 amRNSForm 8.5 (EPT/NON-RI)
22nd Jan 20218:42 amRNSForm 8.5 (EPT/NON-RI)
21st Jan 20219:10 amRNSForm 8.5 (EPT/NON-RI)
20th Jan 20218:56 amRNSForm 8.5 (EPT/NON-RI)
19th Jan 20218:15 amRNSForm 8.5 (EPT/NON-RI)
18th Jan 20218:06 amRNSForm 8.5 (EPT/NON-RI)
14th Jan 20219:11 amRNSForm 8.5 (EPT/NON-RI)
13th Jan 20218:40 amRNSForm 8.5 (EPT/NON-RI)
12th Jan 20219:08 amRNSForm 8.5 (EPT/NON-RI)
11th Jan 202110:22 amRNSForm 8.5 (EPT/NON-RI)
7th Jan 20218:28 amRNSForm 8.5 (EPT/NON-RI)
6th Jan 20218:23 amRNSForm 8.5 (EPT/NON-RI)
5th Jan 20219:13 amRNSForm 8.5 (EPT/NON-RI)
4th Jan 20214:34 pmRNSEBT Share Purchase Plan
31st Dec 202011:36 amRNSForm 8.5 (EPT/NON-RI)
29th Dec 20208:25 amRNSForm 8.5 (EPT/NON-RI)
21st Dec 20208:57 amRNSForm 8.5 (EPT/NON-RI)
17th Dec 20208:59 amRNSForm 8.5 (EPT/NON-RI)
16th Dec 20208:43 amRNSForm 8.5 (EPT/NON-RI)
14th Dec 20208:49 amRNSForm 8.5 (EPT/NON-RI)
11th Dec 20209:54 amRNSForm 8.5 (EPT/NON-RI)
10th Dec 20208:34 amRNSForm 8.5 (EPT/NON-RI)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.